Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 2313 Glioblastoma 2016 Glioma 1402 Central Nervous System Neoplasms 692 Astrocytoma 668 Neuroblastoma 647 Gliosarcoma 480 Oligodendroglioma 405 Neoplasms 405 Breast Neoplasms 327 Medulloblastoma 307 Carcinoma, Non-Small-Cell Lung 256 Meningioma 229 Recurrence 224 Sarcoma 215 Melanoma 207 Neoplasm Metastasis 202 Ependymoma 200 Lung Neoplasms 199 Neurofibromatosis 1 169 Lymphoma 162 Meningeal Carcinomatosis 138 Osteosarcoma 135 Ovarian Neoplasms 132 Wilms Tumor 123 Precursor Cell Lymphoblastic Leukemia-Lymphoma 123 Head and Neck Neoplasms 117 Lymphoma, Non-Hodgkin 116 Diffuse Intrinsic Pontine Glioma 113 Rhabdomyosarcoma 107

Interventions

Radiotherapy 1 Metformin 1 Hypoglycemic Agents 1 Diet, Carbohydrate-Restricted 1 Biguanides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Ketosis × CNS × Clear all

NCT02149459 2017-10-27

SMC 0712-13

Sheba Medical Center

Phase 1 Unknown

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Insulin Resistance, Ketosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡